Demographic disparities in teprotumumab use for thyroid eye disease in the United States

White patients were disproportionately more likely to be prescribed teprotumumab than Black patients, potentially due to prescriber bias, socioeconomic challenges, and medical distrust. Trends show progress towards more equitable distribution.

Authors

Anne Barmettler
Jee‐Young Moon (ORCID: https://orcid.org/0000-0001-9218-8335)
Lalita Gupta
Troy Karanfilian

Institutions

Albert Einstein College of Medicine (US)

Publication Details

Journal: Orbit
Published: 2025-12-31
DOI: https://doi.org/10.1080/01676830.2025.2601126
Primary Topic: Ophthalmology and Eye Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Demographic disparities in teprotumumab use for thyroid eye disease in the United States

Anne Barmettler, Jee‐Young Moon, Lalita Gupta, Troy Karanfilian

Dec 31, 2025

Orbit

Ophthalmology and Eye Disorders

article

Demographic disparities in teprotumumab use for thyroid eye disease in the United States

Anne Barmettler, Jee‐Young Moon, Lalita Gupta, Troy Karanfilian

December 31, 2025article en

Abstract

OrbitVol. 45(2)

Albert Einstein College of Medicine (US)

Openalex Percentile: Top 29%

Ophthalmology and Eye Disorders

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Demographic disparities in teprotumumab use for thyroid eye disease in the United States — Anne Barmettler, Jee‐Young Moon, et al. · Orbit (2025) | TGRS Research Map | TGRS